On ECHEMI
Home > Drugs > Apremilast Registered Holders
Apremilast structure

Apremilast structure

Apremilast

Apremilast is an orally available inhibitor of type-4 cyclic nucleotide phosphodiesterase (PDE-4) with an IC50 of 74 nM.

Find 51 Related Holders

ZHEJIANG HUAYI PHARMACEUTICAL CO LTD
United States United States

API Registration Country

API Active
ANHUI POLY PHARM CO LTD
United States United States

API Registration Country

API Active
Changzhou Pharmaceutical Factory
United States United States

API Registration Country

API Active
Sun Pharmaceutical Industries Ltd
United States United States

API Registration Country

API Active
Unichem Laboratories Ltd
United States United States

API Registration Country

API Active
ScinoPharm Taiwan Ltd
United States United States

API Registration Country

API Active
ZHEJIANG HUAHAI PHARMACEUTICAL CO LTD
United States United States

API Registration Country

API Active
LEK PHARMACEUTICALS DD
United States United States

API Registration Country

API Active
Reyoung Pharmaceutical Co., Ltd.
China China

API Registration Country

API Inactive
  • Founded in:

    1998-03-20
  • Country:

    China China
  • Address:

    No. 1, Ruiyang Road, Yiyuan County, Shandong Province
  • Tax NO.:

    913703001686121827
  • Registered Funds:

    366.74 million yuan
  • Website:

  • Email:

Zhejiang Jinhua Conba BIO-PHARM. Co., Ltd.
China China

API Registration Country

API Inactive
  • Founded in:

    2000-05-26
  • Country:

    China China
  • Address:

    No. 288, Jinqu Road, Jinhua City, Zhejiang Province
  • Tax NO.:

    913307011472897859
  • Registered Funds:

    520 million yuan
  • Website:

  • Email:

Recommended Suppliers of Apremilast
View 91 Suppliers Request for Quotation
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.